XOMA News and Press, XOMA Corporation From 03/29/21

Should Investors Be Watching These Top Health Care Stocks Right Now? Most would know that health care stocks are amongst the top performers throughout the current pandemic. Some might even say that the sector is among the best to invest in now. For one thing, the industry is hom...

XOMA Corporation ([[XOMA]] +20.5%) has gained more than a fifth of its value and if the rally holds, the stock could end up with its biggest one-day gain since September 2017.A few days ago, XOMA announced the purchase of potential future milestones and royalties linked to two clini...

Gainers: Wah Fu Education (WAFU) +214%.China Liberal Education (CLEU) +37%.Helius Medical Technologies (HSDT) +34%.Four Seasons Education (FEDU) +31%.MagnaChip Semiconductor (MX) +27%.FreightCar America (RAIL) +25%.NextDecade (NEXT) +25%.180 Life Sciences (ATNF) +25%.XOMA (XOMA...

Viracta and XOMA Announce Multi-License Milestone and Royalty Monetization Transaction Viracta to Receive $13.5 Million Upfront Cash Payment XOMA to Receive Economics on Two Clinical-Stage Partnered Programs PR Newswire SAN DIEGO and EMERYVILLE, Calif. , ...

EMERYVILLE, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors approved a dividend of $0.71875 per share to holders of XOMA’s Series A Cumulative Perpetual Preferred S...

XOMA (XOMA): Q4 GAAP EPS of $1.32 misses by $0.68.Revenue of $27.6M (+6471.4% Y/Y) beats by $10.35M.Press Release For further details see: XOMA EPS misses by $0.68, beats on revenue

Recognized revenue of $29.4 million Six assets in the Company’s milestone and royalty portfolio advanced to Phase 2 clinical development Completed $24.6 million Series A Perpetual Preferred Stock offering paying a 8.625% dividend Ended 2020 with $84.2 million in c...

XOMA has built a large portfolio of drug royalties, over 65, with the potential to build a biotechnology business with high upside but limited and diversified downside protection. This royalty aggregator model has the potential to build a substantial balance sheet for XOMA, which will...

EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present at two upcoming investor conferences: H.C. Wainwright Virtual BioConnect 2021 Conference taking place January 11-14, 2021.  ...

EMERYVILLE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the closing of its previously announced underwritten registered public offering of 984,000 shares, which includes the underwriters opti...